This site is intended for healthcare professionals only
LoginRegister
Aurobindo pharmaAurobindo Pharma Gets HC Relief in Compensation Cess Refund Dispute, GST Orders Quashed
Biocon Biologics Secures BB+ Rating Upgrade from S&P on Improved Financial MetricsUSFDA issues EIR for Biocon Generics Cranbury facility
Lupin Gets Zero USFDA Observations for Nagpur PlantLupin, Neopharmed sign licensing pact for Gastro brand Plasil in Brazil, Philippines
Indian Pharma Market Kicks Off 2026 With 10% Growth in January: PharmaTracIndia pharma market expected to hit USD 130 bn by 2030: Commerce Secretary
Same Quality, 14X Price: Study Finds No Difference Between Branded and Generic DrugsGeneric Medicine Production Rises 26% to Rs 4.06 Lakh Cr in Three Years, Parliament Informed
CDSCO Clears AstraZenecas Imfinzi (Durvalumab) for Additional Cancer Indication in IndiaAstraZeneca Pharma India wins CDSCO permission to import breast cancer drug Datverzo
DCGI Moves to Enforce 2009 Ban on Single-Drug Artemisinin Pills Amid Resistance Concerns: ReportDCGI Moves to Enforce 2009 Ban on Single-Drug Artemisinin Pills Amid Resistance Concerns: Report
Substandard Deworming Medicines DetectedOver 14,300 Drug Samples Fail Quality Tests in Five Years: Minister
Sun Pharma Rules Out Big-Bang Acquisitions, Bets on Organic Growth and BiosimilarsSun Pharma Baska facility gets OAI status from USFDA
Alembic Launches First Branded Drug Pivya in US for UTI TreatmentAlembic Pharma secures USFDA approval for Glaucoma treatment
New Book on Hypertension Launched During The 77th Annual Conference of Cardiology Society Of IndiaNew Book on Hypertension Launched During The 77th Annual Conference of Cardiology Society Of India
Aurobindo Pharma arm Unit IV gets 5 USFDA observationsAurobindo Pharma arm Unit IV gets 5 USFDA observations
X